Physician profile
Michael Clay Lyons
NPI 1922234723
$10,437.82
in general payments reported to CMS, 2019-2025
18 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,516 · 2020: $4,616 · 2021: $1,193 · 2022: $1,441 · 2023: $267 · 2024: $115 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trilliant Surgical LLC. | $3,000.00 | 2019-2020 | |
| Arthrex, INC. | $2,337.12 | 2020 | |
| Paragon 28, INC. | $1,980.48 | 2020-2023 | Grappler, Ankle Fracture |
| Stryker Corporation | $1,627.68 | 2019-2025 | Augment Injectable, Anchorage, Easyfuse |
| Crossroads Orthopedics, LLC | $769.52 | 2020-2022 | |
| Smith+Nephew, INC. | $150.39 | 2019-2024 | Renasys Go V2 Home, Renasys, Pico 7 |
| Rti Surgical, INC | $131.09 | 2023 | |
| Bioventus LLC | $97.32 | 2019-2021 | |
| Organogenesis INC. | $70.30 | 2023-2024 | Puraply |
| Grt US Holding, INC. | $65.86 | 2021 | |
| Kerecis Limited | $42.73 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Tactile Systems Technology INC | $40.09 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $32.32 | 2020-2021 | |
| Treace Medical Concepts, INC. | $24.20 | 2023 | |
| Averitas Pharma INC. | $21.58 | 2025 | Qutenza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $16.82 | 2022 | |
| Allergan, INC. | $16.48 | 2020 | |
| Solventum Corporation | $13.84 | 2024 | Prevena, V.A.C.Instill, Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.